Measurement of nasal potential difference in mild asthmatics

Chest

Volumn 123, Issue 5, 2003, Pages 1467-1471

  Chung, Nancy C ^a   Illek, Beate ^b   Widdicombe, Jonathan H ^c   Fischer, Horst ^a,b  

^a CHILDREN S HOSPITAL OAKLAND   (United States)

^b CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Airway epithelial ion transport; Cystic fibrosis; Mucous secretions; Reactive airways disease

Indexed keywords

AMILORIDE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHLORIDE; ISOPRENALINE; SODIUM CHLORIDE;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; ION TRANSPORT; MALE; MEASUREMENT; MEMBRANE TRANSPORT; MUCUS SECRETION; NOSE MUCOSA; PERFUSION; PILOT STUDY; POTENTIAL DIFFERENCE; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; SKIN ELECTRODE; TECHNIQUE; WATER TRANSPORT;

EID: 0037879074     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.123.5.1467     Document Type: Article

References (28)

1. National Asthma Education and Prevention Program. Expert panel report 2: Guidelines for the diagnosis and management of asthma. Washington, DC: US Government Printing Office, 1997; National Heart, Lung, and Blood Institute Publication No. 97-4051
2. Quinton PM. Defective epithelial ion transport in cystic fibrosis. Clin Chem 1989; 35:726-730
3. Javaraman S, Joo NS, Reitz B, et al. Submucosal gland secretions in airways from cystic fibrosis patients have normal [Na+] and pH but elevated viscosity. Proc Natl Acad Sci U S A 2001; 98:8119-8123
4. Yamaya M, Finkbeiner WE, Widdicombe JH. Altered ion transport by tracheal glands in cystic fibrosis. Am J Physiol 1991; 261:L491-L494
5. Jiang C, Finkbeiner WE, Widdicombe JH, et al. Fluid transport across cultures of human tracheal glands is altered in cystic fibrosis. J Physiol 1997; 501:637-647
6. Matsui H, Grubb BR, Tartan R, et al. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell 1998; 95:1005-1015
7. Wilson DC, Ellis L, Zielenski J, et al. Uncertainty in the diagnosis of cystic fibrosis: possible role of in vivo nasal potential difference measurements. J Pediatr 1998; 132:596-599
8. Alton EWFW, Currie AD, Logan-Sinclair R, et al. Nasal potential difference: a clinical test for cystic fibrosis. Eur Respir J 1990; 3:922-926
9. Knowles MR, Paradiso AM, Boucher RC. In vivo nasal potential difference: techniques and protocols for assessing efficacy of gene transfer in cystic fibrosis. Hum Gene Ther 1995; 6:445-455
10. Anderson MP, Rich DP, Gregory RJ, et al. Generation of cAMP-activated chloride currents by expression of CFTR. Science 1991; 251:679-682
11. Knowles MR, Carson JL, Collier AM, et al. Measurements of nasal transepithelial electric potential differences in normal human subjects in vivo. Am Rev Respir Dis 1981; 124:484-490
12. Knowles MR, Buntin WH, Bromberg PA, et al. Measurements of transepithelial electric potential differences in the trachea and bronchi of human subjects in vivo. Am Rev Respir Dis 1982; 126:108-112
13. Vinuya RZ. Upper airway disorders and asthma: a syndrome of airway inflammation. Ann Allergy Asthma Immunol 2002; 88:8-15
14. Grossman J. One airway, one disease. Chest 1997; 111:11S-16S
15. de Benedictis FM, del Giudice MM, Severini S, et al. Rhinitis, sinusitis and asthma: one linked airway disease. Paediatr Respir Rev 2001; 2:358-364
16. Boat TF, Kleinerman JI. Human respiratory tract secretions: 2. Effect of cholinergic and adrenergic agents on in vitro release of protein and mucous glycoprotein. Chest 1975; 67:32S-34S
17. 2 adrenostimulant fenoterol. J Allergy Clin Immunol 1980; 66:25-32
18. Buckle FG, Cohen AB. Nasal mucosal hyperpermeability to macromolecules in atopic rhinitis and extrinsic asthma. J Allergy Clin Immunol 1975; 55:213-221
19. Jackson RT, Turner JS. Some observations on nasal pH. Arch Otolaryngol 1966; 84:446-450
20. Lorin MI, Gaerlan PF, Mandel ID. Quantitative composition of nasal secretions in normal subjects. J Lab Clin Med 1972; 80:275-281
21. Quinlan MF, Salman SD, Swift DL, et al. Measurement of mucociliary function in man. Am Rev Respir Dis 1969; 99:13-23
22. Illek B, Fischer H. Flavonoids stimulate Cl conductance of human airway epithelium in vitro and in vivo. Am J Physiol 1998; 275:L902-L910
23. Sauder RA, Chesrown SE, Loughlin GM. Clinical application of transepithelial potential difference measurements in cystic fibrosis. J Pediatr 1987; 111:353-358
24. Rosenstein BJ, Cutting GR. The diagnosis of cystic fibrosis: a consensus statement; Cystic Fibrosis Foundation Consensus Panel. J Pediatr 1998; 132:589-595
25. Carroll N, Elliot J, Morton A, et 'al. The structure of large and small airways in nonfatal and fatal asthma. Am Rev Respir Dis 1993; 147:405-410
26. Fukuda N, Jayr C, Lazrak A, et al. Mechanisms of TNF-α stimulation of amiloride-sensitive sodium transport across alveolar epithelium. Am J Physiol Lung Cell Mol Physiol 2001; 280:L1258-L1265
27. Elmer HL, Brady KG, Drumm ML, et al. Nitric oxide-mediated regulation of transepithelial sodium and chloride transport in murine nasal epithelium. Am J Physiol 1999; 276:L466-L473
28. Ding JW, Dickie J, O'Brodovich H, et al. Inhibition of amiloride-sensitive sodium-channel activity in distal lung epithelial cells by nitric oxide. Am J Physiol Lung Cell Mol Physiol 1998; 274:L378-L387